65,437 trials
Type 2 Diabetes Mellitus · Cardiovascular Disease · Hypertension
Primary: Adjusted Mean Change in HbA1c Levels — -0.38; 0.08 Percent — p=<0.0001
Scoliosis
Primary: Motor Evoked Potential Amplitude — 1; 3; 1; 4 participants
Primary Care Appointment Keeping
Primary: The Percentage of Patients Attending a Primary Care Visit in Each of 3 Four-month Periods (First Measure) — 55.8; 55.6; 45.7 percent in care each 4 month period
Breast Reconstruction · Breast Augmentation · Breast Revision
Primary: 10-Year Kaplan-Meier Estimated Cumulative Incidence Rate of Occurrence of Any Reoperation — 25.5; 49.0; 43.6; 50.7 percentage of subjects
Pulmonary Fibrosis · Hypertension, Pulmonary
Primary: Change in 6-minute Walk Distance From Enrollment to Week 12 (≥ 20% Improvement) — 9; 6 participants — p=0.39
Anthocyanin Metabolism
Primary: Gastric pH — 0.96; 2.31 pH
Ovarian Cancer
Primary: Overall Response Rate (ORR) — 0; 0 participants
Colorectal Cancer
Primary: Time to Intubate the Cecum — 271; 403 seconds
Type 2 Diabetes Mellitus · Cardiovascular Disease · Inadequate Glycaemic Control
Primary: Adjusted Mean Change in HbA1c Levels — -0.33; 0.07 Percent — p=<0.0001
Type 2 Diabetes
Primary: Adjusted Mean Change in HbA1c Levels — -0.30; -0.75; -0.82; -0.90 Percent — p=<0.0001
Ovarian Cancer
Primary: Progression-Free Survival (PFS): Independent Radiologist Review — 5.8; 7.3 Months — p=0.0190
Endometriosis
Primary: Percentage Changes of Serum Anti-Mullerian Hormone (AMH) at 2-week and 3-month Post Operation — -56.86; -77.72; -36.69; -66.84 percentage of serum AMH change
Type 2 Diabetes
Primary: Adjusted Mean Change in HbA1c Levels — -0.52; -0.52 percent — p=<0.0001
Smoking
Primary: Change From Baseline in Attitude Score — .64; -.25 units on a scale
Severe Sepsis · Septic Shock
Primary: Safety and Tolerability of AZD9773 — 7; 7; 6; 1 Participants